IADSA update on international supplement regulations

Market Alerts

July 2022

June 2022

May 2022

April 2022

February 2022

November 2021

  • SCNM Dedicates Ric Scalzo Institute of Botanical Research
  • August 2021

    July 2021

    March 2021

    February 2021

    November 2020

    October 2020

    September 2020

    August 2020

    July 2020

    June 2020

    April 2020

    February 2020

    January 2020

  • Sabinsa's parent company Sami Labs breaks ground on $30 million state of the art production facility
  • Unstoppable Moms Across America launches new Gold Standard to shift the marketplace for a healthier planet
  • Draco Achieves Safe Quality Food (SQF) certification of its manufacturing facilities
  • August 2019

    June 2019

    May 2019

    March 2019

    February 2019

    January 2019

    December 2018

    November 2018

    October 2018

    September 2018

    August 2018

    July 2018

    May 2018

    April 2018

    March 2018

    February 2018

    January 2018

    December 2017

    November 2017

    October 2017

    September 2017

    August 2017

    July 2017

    June 2017

    IADSA update on international supplement regulations

    December 2019 IADSA Newsflash

    Published: Wednesday, December 18, 2019

    AHPA is an active member of IADSA and is distributing the IADSA Newsflash as a member benefit. IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash covers:

    • China has announced new health food naming guidelines for 2019, which include several naming conventions that must be included on labels.
    • The European Commission has recently lowered the level of citrinin (a mycotoxin) in food supplements based on rice fermented with red yeast Monascus purpureus to 100 µg/kg effective April 1, 2020. The previously allowed level was 2000 µg/kg, but evaluation of recent toxicity data and occurrence data in red yeast rice prompted the change.
    • In Belgium, the intake of curcuminoids with their natural bioavailability (original bioavailability, present by nature/not reinforced by using other substances such as piperin/quercetin) must be limited to 500 mg of curcuminoids per day. A brief review by AHPA has indicated that recommended dosages in excess of 500 mg/day are not uncommon so marketers selling in the Belgium market may wish to review their product usage recommendations. Belgium Has also introduced some labeling requirements.
    • French authorities have recently issued a caution for the intake of supplements containing berberine. The agency cited adverse effects at doses over 600 mg/day and potential interactions with some medications.
    • Poland continues to work on determining limits for some food supplement ingredients, including caffeine.

    Download the December 2019 issue >>

    Print

    2022 Annual Fund Sponsors

    AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.